Connor Clark & Lunn Investment Management Ltd. Increases Stake in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Free Report) by 106.2% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 171,332 shares of the company’s stock after purchasing an additional 88,224 shares during the period. Connor […]
